Faculty Perspectives: Prevalence, Burden, Epidemiology, and Pathophysiology of Asthma

Supplements
Asthma remains a significant public health issue, affecting approximately 25 million individuals in the United States alone. Despite the availability of evidence-based guidelines and newer, more effective therapies, adequate control of symptoms may be challenging, resulting in diminished quality of life, and in some cases, life-threatening exacerbations. Faculty Perspectives™ is a 4-part series addressing the latest issues in the care of patients with asthma. In this first issue, faculty experts discuss the prevalence, burden, epidemiology, and pathophysiology of the disease, the role of managed care pharmacy, and trends in management.

Download PDF
Last modified: March 20, 2015
  • American Health & Drug Benefits
  • The Journal of Hematology Oncology Pharmacy
  • Lynx CME
  • The Oncology Pharmacist

Search